Sana Biotechnology, Inc. Common Stock
Symbol: SANA (NASDAQ)
0.00
▼ (-100.00%) -3.550
Company Description:
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.
Key Stats
- Today's Open: $0
- Today's High: $0
- Today's Low: $0
- Today's Volume: 0
- Yesterday Close: $3.55
- Yesterday High: $3.585
- Yesterday Low: $3.42
- Yesterday Volume: 2.23M
- Last Min Volume: 0
- Last Min High: $0
- Last Min Low: $0
- Last Min VWAP: $0
Company Profile
- Name: Sana Biotechnology, Inc. Common Stock
- Website: https://www.sana.com
- Listed Date: 2021-02-04
- Location: SEATTLE, WA
- Market Status: Active
- CIK Number: 0001770121
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $910.67M
- Round Lot: 100
- Outstanding Shares: 257.25M
- Asset Type: CS
RECENT FILINGS FOR SANA
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-05 | 8-K | View |
| 2025-08-29 | 8-K | View |
| 2025-08-11 | 10-Q | View |
| 2025-08-11 | 8-K | View |
| 2025-08-07 | 8-K | View |
| 2025-08-07 | 424B5 | View |
| 2025-08-06 | 424B5 | View |
| 2025-08-06 | 8-K | View |
| 2025-07-08 | 4 | View |
| 2025-06-23 | 8-K | View |
| 2025-06-09 | 4 | View |
| 2025-06-09 | 4 | View |
| 2025-06-09 | 4 | View |
| 2025-06-09 | 4 | View |
| 2025-06-09 | 4 | View |
| 2025-06-09 | 4 | View |
| 2025-06-09 | 4 | View |
| 2025-06-09 | 4 | View |
| 2025-06-09 | 4 | View |
| 2025-06-09 | 3 | View |
Latest News on SANA